β-Catenin gene (CTNNB1) mutations are one of the major oncogenic gene alterations in HCC seen in 10–40%, while mutations affecting Axin1 are seen in around 10% of all HCCs [2]. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.